|
SP1
|
Specific protein 1
|
F:5′-ACTGAGATCCCCAAAACACC-3′; R:5′-TTCTCTGCCCTCACTCTTGA-3′
|
2.00
|
3.81
|
Transcriptional factor
|
|
STAT3
|
Signal transducer and activator of transcription 3
|
F:5′-TCACTTGGGTGGAAAAGGAC-3′; R:GGAATGTCGGGGTAGAGGTAG-3′
|
1.89
|
2.35
|
Transcriptional factor
|
|
Jun
|
Jun proto-oncogene
|
F:5′-CCTTCTACGACGATGCCCTC-3′; R:5′-GGTTCAAGGTCATGCTCTGTTT-3′
|
3.01
|
3.94
|
Transcriptional factor
|
|
Fas
|
Fas cell surface death receptor
|
F:5′-GCAGACATGCTGTGGATCTGG-3′; R:5′-TCACAGCCAGGAGAATCGCAG-3′
|
5.10
|
2.18
|
Transcriptional factor
|
|
FGF7
|
Fibroblast growth factor 7 (keratinocyte growth factor)
|
F:5′-ACGGCTACGAGTGTGAACTGT-3′; R:5′-TTTCACTTTGCCTCGTTTGTC-3′
|
75.96
|
42
|
Growth factor
|
|
BDNF
|
Brain-derived neurotrophic factor
|
F:5′-GCCTCCTCTACTCTTTCTGCTG-3′; R:5′-TGTGACCCACTCGCTAATACTG-3′
|
2.68
|
5.76
|
Growth factor
|
|
VEGFD (FIGF)
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
F:5′-AGCACCTCCTACATCTCCAAAC-3′; R:5′-CATTCATCTTCTTCTGGGGTCT-3′
|
4.82
|
5.76
|
Growth factor
|
|
IGF1
|
Insulin-like growth factor 1
|
F:5′-AAAATCAGCAGCCTTCCAACT-3′; R:5′-CCTGTGGGCTTGTTGAAGTAA-3′
|
2.17
|
3.13
|
Growth factor
|
|
PTN
|
Pleiotrophin
|
F:5′-CTCTGCACAATGCTGACTGTC-3′; R:5′-CTTTGACTCCGCTTGAGGCTT-3′
|
31.78
|
36
|
Growth factor
|
|
PDGFα
|
Platelet-derived growth factor, alpha
|
F:5′-TGGCTCGAAGTCAGATCCACA-3′; R:5′-TTCTCGGGCACATGGTTAATG-3′
|
1.61
|
1.229
|
Growth factor
|
|
IGFBP3
|
Insulin-like growth factor binding protein 3
|
F:5′-TCCAGGAAACATCAGTGAGTCCGA-3′; R:5′-CATACTTGTCCACACACCAGCAGA-3′
|
22.75
|
27.84
|
Insulin-like growth factor binding protein
|
|
Col I
|
collagen, type I
|
F:5′-GCTCCTCTTAGGGGCCACT-3′; R:5′-CCACGTCTCACCATTGGGG-3′
|
3.56
|
1.6
|
Fibrogenesis
|
|
FN1
|
Fibronectin 1
|
F:5′-TTCAAGTGTGATCCCCATGAAG-3′; R:5′-CAGGTCTACGGCAGTTGTCA-3′
|
7.34
|
5.26
|
Fibrogenesis
|
|
TIMP2
|
Tissue inhibitors of metalloproteinase 2
|
F:5′-CTGGACGTTGGAGGAAAGAAG-3′; R:5′-CTGGGTGATGCTAAGCGTGTC-3′
|
2.01
|
3.456
|
Matrix remodeling
|
|
TIMP3
|
Tissue inhibitors of metalloproteinase 3
|
F:5′-GCAAGGGCCTCAATTACCG-3′; R: 5′-AGGCGTAGTGTTTGGACTGATA-3′
|
8.57
|
10.389
|
Matrix remodeling
|
|
MMP2
|
Matrix metalloproteinase 2
|
F:5′-GTGTCTTCCCCTTCACTTTCCT-3′; R:5′-CATCATCGTAGTTGGTTGTGGT-3′
|
8.07
|
10.24
|
Matrix remodeling
|
|
IL6
|
Interleukin 6
|
F:5′-GGAGAGGAGACTTCACAGAGGA-3′; R:5′-ATTTCCACGATTTCCCAGAGA-3′
|
3.00
|
1.74
|
Inflammatory factor
|
|
CXCR7
|
Chemokine (C-X-C motif) receptor 7
|
F:5′-AGCCTGGCAACTACTCTGACA-3′; R:5′-GAAGCACGTTCTTGTTAGGCA-3′
|
11.31
|
14.42
|
Chemokine receptor
|
|
CXCL11
|
Chemokine (C-X-C motif) ligand 11
|
F:5′-GGCTTCCTTATGTTCAAACAGGG-3′; R:5′-GCCGTTACTCGGGTAAATTACA-3′
|
2.03
|
0.65
|
Chemokine
|
|
CXCL12
|
Chemokine (C-X-C motif) ligand 12
|
F:5′-ACTGTGCCCTTCAGATTGTTG-3′; R:5′-CAGCCTTTCTCTTCTTCTGTCG-3′
|
44.84
|
34.95
|
Chemokine
|
|
CASP2
|
Caspase 2
|
F:5′-GCAAGATGGAAAGAACCACAC-3′; R:5′-GCAAGATGGAAAGAACCACAC-3′
|
1.83
|
1.7
|
Apoptin
|
|
DLK1
|
Delta-like 1 homolog (Drosophila)
|
F:5′-AGTGCGAAACCTGGGTGTC-3′; R:5′-GCCTCCTTGTTGAAAGTGGTCA-3′
|
18.95
|
19.784
|
Tumor repressor, cell differentiation
|
|
AKT3
|
Thymoma viral proto-oncogene homolog 3
|
F:5′-GTGGACTTACCTTATCCCCTCA-3′; R:5′-TTGGCTTTGGTCGTTCTGTTT-3′
|
2.50
|
3.27
|
Serine/threonine protein kinase
|
|
GNG2
|
Guanine nucleotide binding protein (G protein), gamma 2
|
F:5′-GAAGCCAACATCGACAGGAT-3′; R:5′-GTTTTCTGAGGCTGGGACTG-3′
|
5.71
|
5.5
|
Signaling transduction
|
|
MDM2
|
E3 ubiquitin protein ligase
|
F:5′-AGATCCTGAGATTTCCTTAGCTGACT-3′; R:5′-TCTCACGAAGGGTCCAGCATCT-3′
|
3.77
|
4
|
Ubiquitination
|
|
Wnt5a
|
Wingless-related MMTV integration site 5A
|
F:5′-CAACTGGCAGGACTTTCTCAA-3′; R:5′-CATCTCCGATGCCGGAACT-3′
|
2.35
|
3.73
|
Modulator of Wnt signaling
|
